Found: 108
Select item for more details and to access through your institution.
Adjuvant systemic therapy of early stage breast cancer.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Caring for the breast cancer survivor.
- Published in:
- Patient Care (Print), 1999, v. 33, n. 7, p. 141
- By:
- Publication type:
- Article
Pituitary adenoma and bilateral male breast cancer: An unusual association.
- Published in:
- Journal of Surgical Oncology, 1997, v. 64, n. 1, p. 74, doi. 10.1002/(SICI)1096-9098(199701)64:1<74::AID-JSO14>3.0.CO;2-W
- By:
- Publication type:
- Article
Social cognitive variables and physical activity during chemotherapy for breast cancer: An intensive longitudinal examination.
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 3, p. 425, doi. 10.1002/pon.5820
- By:
- Publication type:
- Article
Eribulin mesylate.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Risk of Recurrence in Patients With HER.2+ Early-Stage Breast Cancer: Literature Analysis of Patient and Disease Characteristics.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 4, p. 350, doi. 10.1016/j.clbc.2023.03.007
- By:
- Publication type:
- Article
A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 3, p. 324, doi. 10.1016/j.clbc.2022.12.006
- By:
- Publication type:
- Article
RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Proceedings of the First Global Workshop on Breast Cancer: Pathways to the Evaluation and Clinical Development of Novel Agents for Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 421, doi. 10.3816/CBC.2010.n.056
- By:
- Publication type:
- Article
High-dose chemotherapy and breast cancer.
- Published in:
- 1999
- By:
- Publication type:
- commentary
The evolving role of endocrine therapy for early stage breast cancer.
- Published in:
- Breast Cancer (13406868), 2005, v. 12, n. 2, p. 62, doi. 10.2325/jbcs.12.62
- By:
- Publication type:
- Article
The Application of Oncotype DX in Early-Stage Lymph-Node-Positive Disease.
- Published in:
- Current Oncology Reports, 2014, v. 16, n. 1, p. 1, doi. 10.1007/s11912-013-0360-2
- By:
- Publication type:
- Article
Obstructing Plasmacytoma of the Duodenum: First Manifestation of Relapsed Multiple Myeloma.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1988, v. 83, n. 1, p. 77
- By:
- Publication type:
- Article
Feasibility and preliminary effects of the Fit2ThriveMB pilot physical activity promotion intervention on physical activity and patient reported outcomes in individuals with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 208, n. 2, p. 391, doi. 10.1007/s10549-024-07432-5
- By:
- Publication type:
- Article
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 207, n. 2, p. 275, doi. 10.1007/s10549-024-07417-4
- By:
- Publication type:
- Article
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 202, n. 1, p. 191, doi. 10.1007/s10549-023-07046-3
- By:
- Publication type:
- Article
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 2, p. 449, doi. 10.1007/s10549-021-06217-4
- By:
- Publication type:
- Article
Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 187, n. 2, p. 397, doi. 10.1007/s10549-021-06236-1
- By:
- Publication type:
- Article
Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 186, n. 2, p. 429, doi. 10.1007/s10549-020-06031-4
- By:
- Publication type:
- Article
The 21-gene recurrence score in node-positive, hormone receptor-positive, HER2-negative breast cancer: a cautionary tale from an NCDB analysis.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 667, doi. 10.1007/s10549-020-05971-1
- By:
- Publication type:
- Article
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 2, p. 377, doi. 10.1007/s10549-019-05226-8
- By:
- Publication type:
- Article
Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 1, p. 95, doi. 10.1007/s10549-018-05088-6
- By:
- Publication type:
- Article
Phase I study of alpelisib (BYL-719) and trastuzumab emtansine (T-DM1) in HER2-positive metastatic breast cancer (MBC) after trastuzumab and taxane therapy.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 2, p. 371, doi. 10.1007/s10549-018-4792-0
- By:
- Publication type:
- Article
Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 3, p. 397, doi. 10.1007/s10549-018-4697-y
- By:
- Publication type:
- Article
Using ecological momentary assessment to understand associations between daily physical activity and symptoms in breast cancer patients undergoing chemotherapy.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 8, p. 6613, doi. 10.1007/s00520-022-07071-w
- By:
- Publication type:
- Article
Current state of clinical trials in breast cancer brain metastases.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 5, p. 392, doi. 10.1093/nop/npz003
- By:
- Publication type:
- Article
ASO Visual Abstract: Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases–An NCDB Analysis.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases: An NCDB Analysis.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 13, p. 8717, doi. 10.1245/s10434-021-10374-7
- By:
- Publication type:
- Article
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 3, p. 765, doi. 10.1245/s10434-019-08039-7
- By:
- Publication type:
- Article
The role of targeted therapy and biomarkers in breast cancer treatment.
- Published in:
- Clinical & Experimental Metastasis, 2012, v. 29, n. 7, p. 807, doi. 10.1007/s10585-012-9496-y
- By:
- Publication type:
- Article
Progress in systemic adjuvant therapy of early-stage breast cancer.
- Published in:
- International Journal of Clinical Oncology, 2003, v. 8, n. 4, p. 239, doi. 10.1007/s10147-003-0338-4
- By:
- Publication type:
- Article
Are Biosimilars the Future of Oncology and Haematology?
- Published in:
- Drugs, 2019, v. 79, n. 15, p. 1609, doi. 10.1007/s40265-019-01193-y
- By:
- Publication type:
- Article
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40061-y
- By:
- Publication type:
- Article
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
The Place for Eribulin in the Treatment of Metastatic Breast Cancer.
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 1, p. 11, doi. 10.1007/s11912-010-0145-9
- By:
- Publication type:
- Article
Hormonal therapy for primary breast cancer: Scientific rationale and status of clinical research.
- Published in:
- Current Oncology Reports, 2005, v. 7, n. 1, p. 31, doi. 10.1007/s11912-005-0023-z
- By:
- Publication type:
- Article
Novel Neoadjuvant Treatment Strategies for Triple-Negative Breast Cancer.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 5, p. 176
- By:
- Publication type:
- Article
Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?
- Published in:
- Oncology (08909091), 2016, v. 30, n. 2, p. 148
- By:
- Publication type:
- Article
The Role of Ovarian Suppression in Premenopausal Women With Hormone Receptor--Positive Early-Stage Breast Cancer... [including commentary by ANN H. PARTRIDGE].
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
The Role of Ovarian Suppression in Premenopausal Women With Hormone Receptor--Positive Early-Stage Breast Cancer... [including commentary by ANN H. PARTRIDGE].
- Published in:
- Oncology (08909091), 2015, v. 29, n. 7, p. 473
- By:
- Publication type:
- Article
Skeletal Issues and Bone Health in Patients With Cancer.
- Published in:
- Oncology (08909091), 2009, v. 23, p. 7
- By:
- Publication type:
- Article
Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer Risk.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2016, v. 5, n. 4, p. 337, doi. 10.1089/jayao.2016.0009
- By:
- Publication type:
- Article
Outcomes of Cancer Patients with COVID-19 in a Hospital System in the Chicago Metropolitan Area.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092209
- By:
- Publication type:
- Article
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Chemotherapy-related hemolytic-uremic syndrome after the treatment of head and neck cancer. A case report.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Ductal Carcinoma In Situ of Breast: From Molecular Etiology to Therapeutic Management.
- Published in:
- Endocrinology, 2022, v. 163, n. 4, p. 1, doi. 10.1210/endocr/bqac027
- By:
- Publication type:
- Article
nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 138, n. 3, p. 829, doi. 10.1007/s10549-013-2447-8
- By:
- Publication type:
- Article
A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103).
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 134, n. 1, p. 345, doi. 10.1007/s10549-012-2071-z
- By:
- Publication type:
- Article